Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on

3

Oct 26 (Reuters) – Drug developers Aspen Neuroscience and Bambusa Therapeutics launched their US initial public offering roadshows on Monday, adding to a wave of issuers from the biotech industry that

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)